Diabetic Macular Edema: What Is Focal and What Is Diffuse?

被引:103
作者
Browning, David J. [1 ]
Altaweel, Michael M. [1 ]
Bressler, Neil M. [1 ]
Bressler, Susan B. [1 ]
Scott, Ingrid U. [1 ]
机构
[1] Jaeb Ctr Hlth Res, Tampa, FL 33647 USA
关键词
D O I
10.1016/j.ajo.2008.07.013
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To review the available information on classification of diabetic macular edema (DME) as focal or diffuse. DESIGN: Interpretive essay. METHODS: Literature review and interpretation. RESULTS: The terms focal diabetic macular edema and diffuse diabetic macular edema frequently are used without clear definitions. Published definitions often use different examination methods and often are inconsistent. Evaluating published information on the prevalence of focal and diffuse DME, the responses of focal and diffuse DME to treatments, and the importance of focal and diffuse DME in assessing prognosis is hindered because the terms are used inconsistently. A newer vocabulary may be more constructive, one that describes discrete components of the concepts such as extent and location of macular thickening involvement of the center of the macula, quantity and pattern of lipid exudates, source of fluorescein leakage, and regional variation in macular thickening and that distinguishes these terms from the use of the term focal when describing one type of photocoagulation technique. Developing methods for assessing component variables that can be used in clinical practice and establishing reproducibility of the methods are important tasks. CONCLUSIONS: Little evidence exists that characteristics of DME described by the terms focal and diffuse help to explain variation in visual acuity or response to treatment. It is unresolved whether a concept of focal and diffuse DME will prove clinically useful despite frequent use of the terms when describing management of DME. Further studies to address the issues are needed. (Am J Ophthalmol 2008;146:649-655. (C) 2008 by Elsevier Inc. All rights reserved.)
引用
收藏
页码:649 / 655
页数:7
相关论文
共 86 条
[1]  
ABU EI, 1991, BR J OPHTHALMOL, V75, P97
[2]   Laser photocoagulation of diabetic macular edema [J].
Akduman, L ;
Olk, RJ .
OPHTHALMIC SURGERY AND LASERS, 1997, 28 (05) :387-408
[3]  
Akduman L, 1999, OPHTHALMIC SURG LAS, V30, P706
[4]  
[Anonymous], 1995, Arch Ophthalmol, V113, P1144
[5]  
[Anonymous], 1991, OPHTHALMOLOGY, V98, P807
[6]  
[Anonymous], 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI [DOI 10.1001/ARCHOPHT.1985.01050120030015, 10.1001/archopht.1985.01050120030015]
[7]   MACULAR MICROCIRCULATION IN CYSTOID MACULOPATHY OF DIABETIC-PATIENTS [J].
AREND, O ;
REMKY, A ;
HARRIS, A ;
BERTRAM, B ;
REIM, M ;
WOLF, S .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1995, 79 (07) :628-632
[8]   Primary intravitreal bevackumab (Avastin) for diabetic macular edema - Results from the Pan-American Collaborative Retina Study Group at 6-month follow-up [J].
Arevalo, J. Fernando ;
Fromow-Guerra, Jans ;
Quiroz-Mercado, Hugo ;
Sanchez, Juan G. ;
Wu, Lihteh ;
Maia, Mauricio ;
Berrocal, Maria H. ;
Solis-Vivancol, Adriana ;
Farah, Michel E. .
OPHTHALMOLOGY, 2007, 114 (04) :743-750
[9]   Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema [J].
Audren, F ;
Tod, M ;
Massin, P ;
Benosman, R ;
Haouchine, B ;
Erginay, A ;
Caulin, C ;
Gaudric, A ;
Bergmann, JF .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (10) :3435-3441
[10]   Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: Phase 2 trial comparing 4 mg vs 2 mg [J].
Audren, Francois ;
Lecleire-Collet, Amelie ;
Erginay, Ali ;
Haouchine, Belkacem ;
Benosman, Rym ;
Bergmann, Jean-Francois ;
Gaudric, Alain ;
Massin, Pascale .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (05) :794-799